Physicians' Academy for Cardiovascular Education

Aspirin discontinuation in CVD prevention is associated with increased CV risk

Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study

Literature - Sundström J, Hedberg J, Thuresson M, et al. - Circulation. 2017;136:1183-1192

Main results


The discontinuation of low-dose long-term aspirin use for CVD prevention in the absence of major surgery or bleeding, was associated with a >30% increased CV risk, shortly after discontinuation. These findings support the use of aspirin in CVD prevention, and justifies further measures to ensure treatment persistence in this setting.


Show references

Find this article online at Circulation

Share this page with your colleagues and friends: